Insmed
INSM
199 hedge funds and large institutions have $3.63B invested in Insmed in 2021 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 67 increasing their positions, 83 reducing their positions, and 27 closing their positions.
24% more call options, than puts
Call options by funds: $4.37M | Put options by funds: $3.52M
1% more capital invested
Capital invested by funds: $3.58B → $3.63B (+$49.9M)
2.15% less ownership
Funds ownership: 105.61% → 103.46% (-2.1%)
3% less funds holding
Funds holding: 206 → 199 (-7)
19% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 27
19% less repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 83
20% less funds holding in top 10
Funds holding in top 10: 5 → 4 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
+$99.3M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$63.1M |
| 3 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$32.9M |
| 4 |
Holocene Advisors
New York
|
+$32.5M |
| 5 |
PAMU
Pictet Asset Management (UK)
London,
United Kingdom
|
+$19.6M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$234M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$35.7M |
| 3 |
State Street
Boston,
Massachusetts
|
-$13.9M |
| 4 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$12.6M |
| 5 |
Goldman Sachs
New York
|
-$12M |
INSM Hedge Fund Activity: Q1 2021 in Review
199 of the 5,711 institutional investors tracked by Wall St. Rank reported a position in Insmed (INSM) for Q1 2021, worth a combined $3.63B — up 1.4% from $3.58B a quarter earlier.
Sellers outnumbered buyers: 27 funds closed out of INSM and 22 opened new positions — a net loss of 5 holders — while 83 trimmed existing stakes and 67 added.
The largest buyer was Point72 Asset Management, adding an estimated $99.3M. The largest seller was Fidelity Investments, cutting an estimated $234M.
- 199 institutional investors held Insmed (INSM) as of Q1 2021, down from 206 in Q4 2020.
- Funds reported $3.63B of Insmed stock for Q1 2021, up 1.4% quarter-over-quarter.
- 22 funds opened new Insmed positions in Q1 2021 and 27 closed out, a net change of -5 holders.
- The largest Insmed buyer in Q1 2021 was Point72 Asset Management, an estimated $99.3M added.
- The largest Insmed seller in Q1 2021 was Fidelity Investments, an estimated $234M sold.
Based on aggregated 13F filings for Q1 2021.